Results 131 to 140 of about 7,517 (258)

A case of extracorporeal photopheresis for HTLV-1 associated myelopathy (HAM).

open access: bronze, 1991
Tatsuo Yudate   +6 more
openalex   +2 more sources

Recognizing indications for photopheresis in acute and chronic Graft-Versus-Host Disease patients [PDF]

open access: hybrid, 2006
Hiba Graham   +6 more
openalex   +1 more source

Eccrine poromatosis following chemotherapy and radiation therapy [PDF]

open access: yes, 2019
Eccrine poroma presents as a single, symptomless erythematous papule in areas with a high density of eccrine sweat glands. Although rare, eccrine poromas can present as multiple lesions, otherwise known as eccrine poromatosis.
Chiu, Melvin, Kim, Gene, Nguyen, Khoa
core  

Pentostatin, TBI and extracorporeal photopheresis for reduced-intensity preparation: Single center adaptation of the Tufts experience [PDF]

open access: hybrid, 2006
Camille N. Abboud   +11 more
openalex   +1 more source

Washington University Record, November 11, 1993 [PDF]

open access: yes, 1993
https://digitalcommons.wustl.edu/record/1635/thumbnail ...

core   +1 more source

TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH PHOTOPHERESIS

open access: bronze, 1998
Roberto Dall’Amico   +1 more
openalex   +1 more source

Effect of Extracorporeal Photopheresis on Steroid Resistant Acute GVHD Refractory to High Dose Steroid Treatment [PDF]

open access: hybrid, 2007
Sung‐Yong Kim   +11 more
openalex   +1 more source

EXTRACORPOREAL PHOTOPHERESIS IN GRAFT-VERSUS-HOST DISEASE.

open access: yesTransplantation and Cellular Therapy, 2023
Pedro Asensi Cantó   +4 more
semanticscholar   +1 more source

European multicenter study on the real-world use and clinical impact of extracorporeal photopheresis after heart transplantation.

open access: yesThe Journal of Heart and Lung Transplantation, 2023
Dr Markus J. Barten   +11 more
semanticscholar   +1 more source

The use of extracorporeal photopheresis in solid organ transplantation—current status and future directions [PDF]

open access: yes
\ua9 2024 The AuthorsPrevention and management of allograft rejection urgently require more effective therapeutic solutions. Current immunosuppressive therapies used in solid organ transplantation, while effective in reducing the risk of acute rejection,
Barten MJ, Fisher AJ, Hertig A
core  

Home - About - Disclaimer - Privacy